Abstract
Cellular immunity is dependent on major histocompatibility complex (MHC) class I molecules enabling cytotoxic T cell recognition of malignant and infected cells. Loading of antigenic peptides onto MHC class I is assisted by a peptide-loading protein complex including tapasin. We found that tapasin expression is enhanced by beta 2-microglobulin via both transcriptional and post-transcriptional mechanisms. In addition, using conditions which preserve the tapasin-ERp57 disulfide-bonded conjugate, we demonstrated that beta 2-microglobulin increases tapasin-containing protein complexes, and reduces the level of MHC class I/ERp57 complexes lacking tapasin. Overall, our results provide a new perspective on the regulation of tapasin expression and association.
Keywords: antigen presentation, beta 2-microglobulin, Db, ERp57, major histocompatibility complex class I, peptide-loading complex, tapasin
1. Introduction
MHC class I molecules are cell-surface receptors for cytotoxic T lymphocytes, allowing them to target and lyse abnormal cells. The binding of peptides, including those derived from viruses and tumor-associated proteins, to heterodimers of MHC class I heavy chains and beta 2-microglobulin (β2m) light chains completes the assembly of MHC class I molecules. Peptide binding to MHC class I molecules is assisted by a group of proteins known as the peptide-loading complex. Members of the MHC class I peptide-loading complex include the transporter associated with antigen processing (TAP), the lectin chaperone calreticulin, the thiol oxidoreductase ERp57, and tapasin. Tapasin plays crucial roles in MHC class I molecule assembly and in shaping the peptide repertoire that is ultimately presented to cytotoxic T lymphocytes [1]. The importance of tapasin for effective cytotoxic T cell-mediated immunity is evidenced by the down-regulation of tapasin in various cancers [2,3]. Tapasin is also targeted by some viruses in order to evade immune detection [4,5]. Recent reports have provided some perspective on how the expression of tapasin itself is regulated. Characterization of the tapasin promoter has shown binding motifs for NF-κB, GATA, E2F1, p300, AP1, SP1, and IRF-1/2 [6,7]. The transcription of tapasin is induced by the cytokines interferon (IFN)-α, IFN-γ and TNF-α [2,8]. Here, we present our findings that tapasin protein levels are lower in cells lacking β2m, and that tapasin protein expression is enhanced by the presence of β2m. Furthermore, tapasin mRNA levels are greater in β2m-expressing cells, as compared to β2m-negative cells, but the difference in mRNA levels is not sufficient to account entirely for the difference in tapasin protein expression. Thus, the mechanisms underlying the effect of β2m on tapasin expression involve both transcriptional and post-transcriptional processes. Furthermore, we observed that β2m increases the level of peptide-loading complexes containing tapasin. In total, our findings demonstrate a new role for β2m in influencing tapasin expression.
2. Materials and Methods
2.1 Cell lines, immunoprecipitations, and western blotting
To determine the effect of β2m on tapasin expression, we used several cell lines differing in β2m expression. The R1.1 cell line was derived from a C58 (H-2k haplotype) mouse thymoma [9]. The R1E cell line was generated from R1.1 cells and has a homozygous mutation of the β2m gene [10]. R1E cells stably transfected with Db alone (R1E-Db) or also transfected with mouse β2m (R1E-Db-β2m) were generated by Dr. R. A. Flavell and co-workers [11]. Daudi is a human Burkitt's lymphoma cell line that lacks β2m expression [12], which we used in our studies in comparison with a β2m transfectant (Daudi-β2m). Immunoprecipitations and western blots were done on cell lysates, using previously described procedures [13]. Protein bands were quantified using a Molecular Imager ChemiDoc XRS system with Quantity One 1-D Analysis Software (Bio-Rad).
2.2 Quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) analysis
For analysis of tapasin mRNA transcripts, the following primers were used: 5’-ACA CTG CGA GAT GAG CCG CT-3’ (forward) and 5’ -GGT CAG CAC CAC TGT TGC CA-3’ (reverse). As a control, the level of mouse glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA was determined using the following primers obtained from PrimerBank (http://pga.mgh.hardvard.edu/primerbank/) (PrimerBank ID 6679937a1): 5’-AGG TCG GTG TGA ACG GAT TTG-3’ (forward) and 5’-TGT AGA CCA TGT AGT TGA GGT CA-3’ (reverse).
RNA was purified from cells using RNAzol-RT (Molecular Research Center), and after purification 500 ng of RNA was used to generate cDNA using the AccuScript High Fidelity 1st Strand cDNA Synthesis Kit (Stratagene). For each qRT-PCR reaction, 1μl of the cDNA reaction was combined with 10μM forward primer, 10μM reverse primer, 12.5μl RT2 SYBR Green qPCR Master Mix (SuperArray Bioscience), and 10.5μl water. The qRT-PCR reactions were analyzed on a Cepheid SmartCycler using Cepheid software version 2.0c. The following thermal cycling program was used: 95°C, 900 s, then 39 cycles of 95°C, 30 s; 55°C, 30 s, and 72°C, 30 s. After completing the thermal cycling program, the following melting curve program was run: 60 to 95°C at 0.2°C per s.
The cycle threshold values were converted into relative expression levels using standard curves generated for the mouse tapasin and mouse GAPDH primers. The relative expression levels obtained from four tapasin and four glyceraldehyde 3-phosphate dehydrogenase (GAPDH) qRT-PCR analyses of a cDNA preparation were averaged. Next, the relative expression of tapasin was normalized to the relative expression of GAPDH for each line. The normalized relative expression of mouse tapasin in R1E cells was set as the control and used to calculate the change in mouse tapasin mRNA expression in the R1.1, R1E-Db, and R1E-Db-β2m cells. According to the results of an F-test, the two-sample equal variance Student's t-test was used to determine the significance of the difference in mouse tapasin mRNA expression in R1E versus R1.1 cells. Results with R1E were compared to results with either R1E-Db or R1E-Db-β2m by the two-sample unequal variance Student's t-test.
3. Results
3.1 Expression of β2m augments murine tapasin protein levels
In our analysis of the R1.1, R1E, R1E-Db, and R1E-Db-β2m cell lines, we noted that β2m, alone or in conjunction with Db, appeared to increase the amount of tapasin protein (Fig. 1a→e). The increase was particularly noticeable for free tapasin. Additionally, β2m enhanced the expression of Db heavy chain (Fig. 1a), consistent with previous reports [14]. Tapasin was also observed in ~145 kD disulfide-bonded complexes, similar in molecular mass to tapasin-containing complexes previously reported by our laboratory [13]. A second complex of ~110-120 kD, representing a conjugate between ERp57 and Db, was found in Db and ERp57 western blots of R1E-Db and R1E-Db-β2m (Fig. 1a,c). This complex was also apparent in immunoprecipitates of Db probed by anti-ERp57 (data not shown). In the presence of β2m, the balance shifted toward the larger (~145 kD) complexes that included tapasin, whereas in the absence of β2m the balance tilted toward the ERp57/Db dimer (Fig. 1a,c). Studies by others have also detected ERp57-MHC class I disulfide-bonded dimers, and implicated ERp57 in the reduction of sub-optimally folded MHC class I prior to its degradation [15,16,17]. In support of this hypothesis, our findings show that the level of the ERp57-Db conjugate (not including tapasin) is enhanced by the absence of β2m, likely due to hampered Db folding.
Fig. 1.
β2m increases the level of mouse tapasin protein existing in free form or in disulfide-linked complexes. Lysates of equal numbers of cells from the indicated cell lines were prepared in methyl methanethiosulfonate to preserve disulfide bonds, and samples of the lysates were added to NuPAGE® lithium dodecyl sulfate (LDS) sample buffer (Invitrogen) +/- 2-mercaptoethanol (2-Me). The samples were then electrophoresed on 10% acrylamide Trisglycine sodium dodecyl sulfate (SDS) gels, transferred to membranes, and probed on western blots with rabbit anti-Db serum (a), hamster anti-mouse tapasin monoclonal antibody (mAb) (b), rabbit anti-mouse ERp57 serum (c), or mouse anti-actin mAb (d). Dotted lines in (a), (b), and (c) indicate areas where lanes were removed. The approximate molecular masses of disulfide-linked complexes on the tapasin, ERp57, and Db blots are indicated with arrows. Additionally, free, non-disulfide-conjugated tapasin, ERp57, and Db molecules are marked with arrows. The Tris-glycine SDS gels used for the tapasin, ERp57 and actin blots were purchased from Invitrogen, whereas the Tris-glycine SDS gel used for the Db blot was from Bio-Rad. Asterisks indicate background bands. (e) Lysates of the indicated cell lines were prepared in iodoacetamide and mixed with NuPAGE® LDS sample buffer containing 2-Me. Actin was used as the loading control, with the loading of samples for the tapasin and actin blots set at the volumes that would yield similar intensities for actin bands. The samples were electrophoresed, transferred, and probed with a hamster anti-mouse tapasin mAb. The antibody was then stripped off, and the membrane was probed with a mouse anti-actin mAb. Densitometry was performed on the tapasin and actin bands of three replicate lysates from each cell line and used to calculate the average tapasin/actin ratio. Cell lines with significantly different tapasin/actin ratios as determined by the two-sample equal variance Student's t-test are indicated with asterisks (* p < 0.05, *** p < 0.001). (f) Electrophoresis, blotting and densitometry were performed as described above, except that a mouse anti-human tapasin mAb was used for the tapasin blot. (g) qRT-PCR was performed to determine the level of mouse tapasin and mouse GAPDH mRNA in the R1E, R1.1, R1E-Db, and R1E-Db-β2m cells, and the data was analyzed as described in the Materials and Methods section. According to results obtained by an F-test, the two-sample equal variance Student's t-test was performed to determine the significance of the difference in the expression of mouse tapasin mRNA in R1.1 compared to R1E cells. For comparison of R1E to either R1E-Db or R1E-Db-β2m, the two-sample unequal variance Student's t-test was performed (* p < 0.05, ** p < 0.01, *** p < 0.001).
By densitometric quantification of western blots, tapasin protein was increased ~4× in R1.1 cells (endogenously expressing β2m) and in cells that express transfected Db and β2m (R1E-Db-β2m), as compared to β2m-negative R1E (Fig. 1e). Expression of transfected Db (without β2m) enhanced tapasin protein expression to ~2.5× that of R1E (Fig. 1e). In contrast, calreticulin expression was not increased by Db and β2m transfection into R1E cells (data not shown). We also compared tapasin expression in Daudi and Daudi-β2m, and (as shown in Fig. 1f) tapasin was increased 1.4× by the presence of human β2m.
3.2 Expression of β2m or the MHC class I heavy chain augments murine tapasin mRNA levels
Variation in tapasin protein levels could be due to differences in tapasin protein stability and/or in regulation of tapasin gene expression. In order to examine the extent to which β2m and/or Db impacts tapasin expression at the mRNA level, we performed qRT-PCR on the R1.1, R1E, R1E-Db, and R1E-Db-β2m cell lines. This analysis revealed that tapasin mRNA levels were enhanced ~2-3× in cells which express β2m, Db, or both β2m and Db (Fig. 1g). Thus, in the R1.1, R1E-Db, and R1E-Db-β2m cell lines, the ~2.5-4× increase in tapasin protein expression may be attributable in part to the concomitant increase in tapasin gene transcription. These data suggest that a mechanism exists to regulate the level of tapasin expression in relation to the level of MHC class I-β2m heterodimers present in the cell. In the R1.1 and R1E-Db-β2m cell lines, tapasin mRNA was enhanced ~2.4×, whereas the level of tapasin protein was increased even more (~4×). Therefore, in the R1.1 and R1E-Db-β2m cell lines, the elevation in tapasin transcription cannot fully account for the nearly 4× enrichment of tapasin at the protein level.
4. Discussion
A plausible explanation for the increase in tapasin protein, above what can be accounted for by increased tapasin transcription, is that Db-β2m heterodimers may stabilize the tapasin protein. Thus, just as tapasin stabilizes MHC class I molecules with open peptide-binding grooves [18], MHC class I heavy chain-β2m heterodimers may reciprocally stabilize tapasin. Tapasin has a long half-life (~24 hours) [19], which precluded our ability to determine the influence of β2m and Db on tapasin protein stability by the use of cycloheximide to inhibit protein synthesis (data not shown). The expression of human tapasin was also enhanced in the presence of β2m in transfected Daudi cells, although the extent of tapasin upregulation was less dramatic than observed in the R1E-Db-β2m cell line. Future studies in our laboratory will address whether the mechanisms controlling tapasin expression differ depending on MHC allotypes present in the cell, as well as how these mechanisms differ among various cell lines and tissues.
Relevant to our data, calreticulin has also been shown to impact mouse tapasin protein levels. In a recent report, Del Cid et al. showed that transfection of calreticulin into calreticulin-deficient mouse cells augmented the steady-state level of tapasin protein [20]. These authors suggested that calreticulin may aid in the folding of nascent tapasin molecules. In light of our findings, it is possible that calreticulin may also contribute to the regulation of tapasin expression indirectly by supporting MHC class I heavy chain and/or β2m stability.
Overall, these studies will assist in uncovering mechanisms that control the stable expression of MHC class I assembly proteins. The MHC class I peptide-loading complex is often disrupted or disregulated in infected and cancerous cells. Thus, understanding the pathways that normally coordinate peptide-loading complex protein expression will advance the development of strategies to restore antigen presentation in the context of infection and cancer.
Highlights.
● Beta 2-microglobulin enhances tapasin expression by a post-transcriptional mechanism.
● Tapasin mRNA levels are also augmented by beta 2-microglobulin.
● Beta 2-microglobulin increases the presence of tapasin-containing protein complexes.
Acknowledgments
This work was supported by NIH Grants R01 GM057428 and GM057428-09S1, a Nebraska DHHS grant, and the Nebraska Center for Cellular Signaling Grants from the National Center for Research Resources (P20 RR18759) and the National Institute of General Medical Sciences (P20 GM103489) (J.C.S.), and a UNMC Graduate Studies/Presidential Fellowship and an NIH/NCI Training Grant T32 CA009476 Fellowship (to L.C.S.). The funding sources had no role in the study design, in the collection, analysis, and interpretation of the data, in the writing of the report, or in the decision to submit the article for publication. We gratefully acknowledge the assistance of Peter Simone with the statistical analysis and Briana Ormsbee with the qRT-PCR assays.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Raghavan M, Del Cid N, Rizvi SM, Peters LR. MHC class I assembly: out and about. Trends Immunol. 2008;29:436–443. doi: 10.1016/j.it.2008.06.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Seliger B, Schreiber K, Delp K, Meissner M, Hammers S, Reichert T, Pawlischko K, Tampe R, Huber C. Downregulation of the constitutive tapasin expression in human tumor cells of distinct origin and its transcriptional upregulation by cytokines. Tissue Antigens. 2001;57:39–45. doi: 10.1034/j.1399-0039.2001.057001039.x. [DOI] [PubMed] [Google Scholar]
- 3.Han LY, Fletcher MS, Urbauer DL, Mueller P, Landen CN, Kamat AA, Lin YG, Merritt WM, Spannuth WA, Deavers MT, De Geest K, Gershenson DM, Lutgendorf SK, Ferrone S, Sood AK. HLA class I antigen processing machinery component expression and intratumoral T-cell infiltrate as independent prognostic markers in ovarian carcinoma. Clin. Cancer Res. 2008;14:3372–3379. doi: 10.1158/1078-0432.CCR-07-4433. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Halenius A, Hauka S, Dolken L, Stindt J, Reinhard H, Wiek C, Hanenberg H, Koszinowski UH, Momburg F, Hengel H. Human cytomegalovirus disrupts the major histocompatibility complex class I peptide-loading complex and inhibits tapasin gene transcription. J. Virol. 2011;85:3473–3485. doi: 10.1128/JVI.01923-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Hansen TH, Bouvier M. MHC class I antigen presentation: learning from viral evasion strategies. Nat. Rev. Immunol. 2009;9:503–513. doi: 10.1038/nri2575. [DOI] [PubMed] [Google Scholar]
- 6.Herrmann F, Trowsdale J, Huber C, Seliger B. Cloning and functional analyses of the mouse tapasin promoter. Immunogenetics. 2003;55:379–388. doi: 10.1007/s00251-003-0597-2. [DOI] [PubMed] [Google Scholar]
- 7.Bukur J, Herrmann F, Handke D, Recktenwald C, Seliger B. Identification of E2F1 as an important transcription factor for the regulation of tapasin expression. J. Biol. Chem. 2010;285:30419–30426. doi: 10.1074/jbc.M109.094284. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Abarca-Heidemann K, Friederichs S, Klamp T, Boehm U, Guethlein LA, Ortmann B. Regulation of the expression of mouse TAP-associated glycoprotein (tapasin) by cytokines. Immunol. Lett. 2002;83:197–207. doi: 10.1016/s0165-2478(02)00104-9. [DOI] [PubMed] [Google Scholar]
- 9.Ralph P. Retention of lymphocyte characteristics by myelomas and theta + - lymphomas: sensitivity to cortisol and phytohemagglutinin. J. Immunol. 1973;110:1470–1475. [PubMed] [Google Scholar]
- 10.Hyman R, Stallings V. Characterization of a TL-variant of a homozygous TL+ mouse lymphoma. Immunogenetics. 1976;3:75–84. [Google Scholar]
- 11.Allen H, Fraser J, Flyer D, Calvin S, Flavell R. Beta 2-microglobulin is not required for cell surface expression of the murine class I histocompatibility antigen H-2Db or of a truncated H-2Db. Proc. Natl. Acad. Sci. USA. 1986;83:7447–7451. doi: 10.1073/pnas.83.19.7447. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Rosa F, Berissi H, Weissenbach J, Maroteaux L, Fellous M, Revel M. The beta2-microglobuliin mRNA in human Daudi cells has a mutated initiation codon but is still inducible by interferon. EMBO. J. 1983;2:239–243. doi: 10.1002/j.1460-2075.1983.tb01412.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Simone LC, Wang X, Tuli A, Solheim JC. Effect of a tapasin mutant on the assembly of the mouse MHC class I molecule H2-Kd. Immunol. Cell. Biol. 2010;88:57–62. doi: 10.1038/icb.2009.59. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Hughes EA, Hammond C, Cresswell P. Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. Proc. Natl. Acad. Sci. USA. 1997;94:1896–1901. doi: 10.1073/pnas.94.5.1896. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Antoniou AN, Santos SG, Campbell EC, Lynch S, Arosa FA, Powis SJ. ERp57 interacts with conserved cysteine residues in the MHC class I peptide-binding groove. FEBS Lett. 2007;581:1988–1992. doi: 10.1016/j.febslet.2007.04.034. [DOI] [PubMed] [Google Scholar]
- 16.Kienast A, Preuss M, Winkler M, Dick TP. Redox regulation of peptide receptivity of major histocompatibility complex class I molecules by ERp57 and tapasin. Nat. Immunol. 2007;8:864–872. doi: 10.1038/ni1483. [DOI] [PubMed] [Google Scholar]
- 17.Lindquist JA, Hammerling GJ, Trowsdale J. ER60/ERp57 forms disulfide-bonded intermediates with MHC class I heavy chain. FASEB J. 2001;15:1448–1450. doi: 10.1096/fj.00-0720fje. [DOI] [PubMed] [Google Scholar]
- 18.Chen M, Bouvier M. Analysis of interactions in a tapasin/class I complex provides a mechanism for peptide selection. EMBO J. 2007;26:1681–1690. doi: 10.1038/sj.emboj.7601624. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Bangia N, Cresswell P. Stoichiometric tapasin interactions in the catalysis of major histocompatibility complex class I molecule assembly. Immunology. 2005;114:346–353. doi: 10.1111/j.1365-2567.2005.02103.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Del Cid N, Jeffery E, Rizvi SM, Stamper E, Peters LR, Brown WC, Provoda C. Modes of calreticulin recruitment to the major histocompatibility complex class I assembly pathway. J. Biol. Chem. 2010;285:4520–4535. doi: 10.1074/jbc.M109.085407. [DOI] [PMC free article] [PubMed] [Google Scholar]

